Here’s why Big Pharma does not like a 80 cents/ month Hydroxychloroquine that Trump mentioned. @AP in bed with Big Pharma. There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye @themotleyfool #stocks $GILD $FTSV https://t.co/FCLDhnQN3R